7 results
Evaluation of Lymphadenopathy - Localized vs Generalized #Diagnosis #EM #IM #Honc #Lymphadenopathy #Localized #Generalized #Infectious #Malignancy
Evaluation of Lymphadenopathy ... vs Generalized #Diagnosis ... #EM #IM #Honc # ... Generalized #Infectious #Malignancy ... Differential #Algorithm #Ddxof
Differential Diagnosis of Hypoglycemia
Evaluation of Hypoglycemia
Patients with known diabetes who are not systemically ill and can
of Hypoglycemia Evaluation ... #EM #IM #Hypoglycemia ... Differential #Algorithm #Drugs ... #Malignancy #Exogenous ... #Hypoglycemic #Ddxof
Differential Diagnosis and Evaluation of Hyponatremia:
1) Identification of onset (acute vs. chronic)
2) Presence of symptoms (HA,
Differential Diagnosis ... and Evaluation ... renal disease), drug ... #EM #IM #Nephro ... Differential #Algorithm #Ddxof
Antinuclear Antibodies (ANA)
ANA or Anti-NucIear Antibody refers to antibodies against antigens in the nucleus → like
likely it will be clinically ... disease (MCTD), Drug-induced ... Non-Rheumatic Diseases: Malignancy ... Biliary Cirrhosis, Drug-Induced ... #rheumatology #diagnosis
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
vs SLE Drug Induced ... to 1:1 F:M • Clinical ... Workup: - ANA ... 40, F:M 9:1 • Clinical ... #rheumatology #diagnosis
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
) Suspect: Clinical ... Differential Diagnosis ... Infections • Malignancy ... extremities Drug ... • Antihistone: Drug
Drug Induced Lupus (DIL)
 • Epidemiology: -10% of all lupus cases, drug-dependent, 4:1 to 1:1 F:M
to 1:1 F:M • Clinical ... is rare in DIL, SCLE-DIL ... Workup: - ANA ... cutaneous-DIL • Evolution ... #rheumatology #diagnosis